Inflammation-targeted single-atom nanozymes drive microglial depolarization and inhibit ferroptosis via Sirt-6-xCT-GPX4 axis to attenuate early brain injury following subarachnoid hemorrhage
Source abstract
Abstract
Early brain injury (EBI) has been identified as a key factor leading to the poor prognosis of patients with subarachnoid hemorrhage (SAH). At present, apart from surgical treatment, there is a lack of effective neuroprotective drugs. In this study, a biomimetic nanozyme V-MDL-800 was constructed by coordinating Vanadium Single-atom enzymes (V/SAE) and the allosteric activator MDL-800 of Sirt6, and encapsulated into NM@V-MDL-800 with neutropenia cell membrane (NM). By clearing ROS, the xCT/GPX4 pathway was activated, blocking the pathophysiological process of EBI after SAH can improve prognosis. NM@V-MDL-800 recruits through the blood-brain barrier (BBB) at the site of hemorrhagic injury by relying on the chemotactic property of neutrophils. Among them, the catalase-like, superoxide dismutase-like, and hydroxyl radical scavenging effects of V/SAE can eliminate excessive reactive oxygen species (ROS) within cells and inhibit oxidative stress; at the same time, as an allosteric activator of Sirt6, it activates the downstream xCT/GPX4 pathway, improving lipid metabolism abnormalities. Regulating the key core pathway of lipid peroxidation on ferroptosis promotes the polarization of microglia from the pro-inflammatory M1 form to the anti-inflammatory M2 morphology to inhibit the pathophysiological process of neuroinflammation in EBI. In addition, in vivo imaging of mice confirmed the targeted effect of NM@V-MDL-800 through the blood-brain barrier and recruited at the site of bleeding injury. The therapeutic effect of NM@V-MDL-800 on the SAH model has also been confirmed in vivo and in vitro experiments. This provides new ideas for SAH drug therapy regimens of SAH targeting microglial ferroptosis.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Intracranial Aneurysms: Treatment and Complications · Advanced Nanomaterials in Catalysis · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (53)
Show source-provided references
1. Spontaneous subarachnoid haemorrhage10.1016/S0140-6736(16)30668-7 ↗
2. Aneurysmal subarachnoid hemorrhage: the last decade10.1007/s12975-020-00867-0 ↗
3. Worldwide incidence of aneurysmal subarachnoid hemorrhage according to Region, time period, blood pressure, and smoking prevalence in the population: a systematic review and meta-analysis10.1001/jamaneurol.2019.0006 ↗
4. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review10.1016/S1474-4422(09)70025-0 ↗
5. Inflammation in the brain after experimental subarachnoid hemorrhage
6. Ferroptosis: an iron-dependent form of nonapoptotic cell death10.1016/j.cell.2012.03.042 ↗
7. Blocking hepatoma-derived growth factor attenuates vasospasm and Neuron cell apoptosis in rats subjected to Subarachnoid hemorrhage10.1007/s12975-021-00928-y ↗
8. Regulation of ferroptotic cancer cell death by GPX410.1016/j.cell.2013.12.010 ↗
9. Molecular basis for redox control by the human cystine/glutamate antiporter system xc(11)10.1038/s41467-021-27414-1 ↗
10. Oroxin A alleviates early brain injury after subarachnoid hemorrhage by regulating ferroptosis and neuroinflammation10.1186/s12974-024-03099-3 ↗
11. Microglia accumulation and activation after subarachnoid hemorrhage10.4103/1673-5374.303028 ↗
12. Excessive phospholipid peroxidation distinguishes ferroptosis from other cell death modes including pyroptosis10.1038/s41419-020-03118-0 ↗
13. Redox lipid reprogramming commands susceptibility of macrophages and microglia to ferroptotic death10.1038/s41589-019-0462-8 ↗
14. Ferroptosis and necroinflammation, a yet poorly explored link10.1038/s41418-018-0173-9 ↗
15. MDM2-GPX4-ferroptosis regulatory axis exerts neurotoxic effects in intracerebral hemorrhage
16. Deacetylase SIRT2 inhibition promotes microglial M2 polarization through Axl/PI3K/AKT to alleviate White matter injury after subarachnoid Hemorrhage10.1007/s12975-024-01282-5 ↗
17. LRP1 activation attenuates white matter injury by modulating microglial polarization through Shc1/PI3K/Akt pathway after subarachnoid hemorrhage in rats10.1016/j.redox.2019.101121 ↗
18. A CoQ10 analog ameliorates cognitive impairment and early brain injury after subarachnoid hemorrhage by regulating ferroptosis and neuroinflammation10.1016/j.redox.2025.103684 ↗
19. The blood-brain barrier in health and disease: important unanswered questions10.1084/jem.20190062 ↗
20. Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging10.1016/j.nano.2011.05.016 ↗
21. Injectable, long-acting PLGA formulations: analyzing PLGA and understanding microparticle formation10.1016/j.jconrel.2019.05.003 ↗
22. Nanoparticles improved resveratrol brain delivery and its therapeutic efficacy against intracerebral hemorrhage10.1039/D0NR06249A ↗
23. Vanadium in biological action: Chemical, pharmacological aspects, and metabolic implications in diabetes mellitus10.1007/s12011-018-1540-6 ↗
24. The age of vanadium-based nanozymes: synthesis, catalytic mechanisms, regulation and biomedical applications10.1016/j.cclet.2023.108793 ↗
25. Natural polyphenol-vanadium oxide nanozymes for synergistic Chemodynamic/Photothermal therapy10.1002/chem.202002335 ↗
26. Vanadium oxide nanozymes with multiple enzyme-mimic activities for tumor catalytic therapy
27. 2D vanadium carbide MXenzyme to alleviate ROS-mediated inflammatory and neurodegenerative diseases10.1038/s41467-021-22278-x ↗
28. Emerging therapeutic potential of SIRT6 modulators10.1021/acs.jmedchem.1c00601 ↗
29. SIRT6 prevent chronic cerebral hypoperfusion induced cognitive impairment by remodeling mitochondrial dynamics in a STAT5-PGAM5-Drp1 dependent manner10.1186/s12967-024-05566-0 ↗
30. Neuroprotective functions for the histone deacetylase SIRT610.1016/j.celrep.2017.03.008 ↗
31. The immunology of acute stroke10.1038/nrneurol.2012.98 ↗
32. Thrombosis, neuroinflammation, and poststroke infection: the multifaceted role of neutrophils in stroke10.1155/2017/5140679 ↗
33. Cell membrane coating nanotechnology10.1002/adma.201706759 ↗
34. Neutrophil-like cell-membrane-coated nanozyme therapy for ischemic brain damage and long-term neurological functional recovery10.1021/acsnano.0c07973 ↗
35. An antioxidant nanozyme that uncovers the cytoprotective potential of vanadia nanowires10.1038/ncomms6301 ↗
36. Self-assembly of multi-nanozymes to mimic an intracellular antioxidant defense system10.1002/anie.201600868 ↗
37. Biomimetic nanoparticles enhance recovery of movement disorders in Parkinson's disease by improving microglial mitochondrial homeostasis and suppressing neuroinflammation10.1021/acsami.4c22181 ↗
38. Platelet membrane-coated Curcumin-PLGA nanoparticles promote Astrocyte-Neuron transdifferentiation for intracerebral hemorrhage treatment10.1002/smll.202311128 ↗
39. Catalytic oxidations by vanadium complexes10.1016/S0010-8545(02)00308-9 ↗
40. Influence of VO2 nanoparticle morphology on the colorimetric assay of H2O2 and glucose10.3390/nano7110347 ↗
41. Sirt6 overexpression relieves ferroptosis and delays the progression of diabetic nephropathy via Nrf2/GPX4 pathway10.1080/0886022X.2024.2377785 ↗
42. The SIRT6/BAP1/xCT signaling axis mediates ferroptosis in cisplatin-induced AKI10.1016/j.cellsig.2024.111479 ↗
43. Baicalin induces ferroptosis in osteosarcomas through a novel Nrf2/xCT/GPX4 regulatory axis10.1016/j.phymed.2023.154881 ↗
44. Optimization and evaluation of an experimental subarachnoid hemorrhage model in mice
45. A new grading system evaluating bleeding scale in filament perforation subarachnoid hemorrhage rat model10.1016/j.jneumeth.2007.08.004 ↗
46. Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation10.1161/01.STR.26.4.627 ↗
47. Melatonin alleviates early brain injury by inhibiting the NRF2-mediated ferroptosis pathway after subarachnoid hemorrhage10.1016/j.freeradbiomed.2023.09.012 ↗
48. Evaluation of learning and memory mechanisms employing elevated plus-maze in rats and mice10.1016/0278-5846(92)90014-6 ↗
49. Noninvasive brain stimulation protects cognitive impairment in i.c.v. STZ-Injected rats: role of adult neurogenesis10.1111/ejn.70277 ↗
50. Ruthenium single-atom nanozyme driven sonosensitizer with oxygen vacancies enhances electron–hole separation efficacy and remodels tumor microenvironment for sonodynamic-amplified ferroptosis
51. Engineering local coordination environment of manganese single-atom enzyme for amplified infected wound therapy10.1016/j.cej.2025.163247 ↗
52. Neutrophil membrane-based biomimetic metal-polyphenol self-assembled nanozyme for the targeting treatment of early brain injury following subarachnoid hemorrhage10.1016/j.cej.2024.155643 ↗
53. Metal-polyphenol self-assembled nanodots for NIR-II fluorescence imaging-guided chemodynamic/photodynamic therapy-amplified ferroptosis10.1016/j.actbio.2024.07.017 ↗